ArticleFrontiers in endocrinology2025

Correction: CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance.

Patricio H Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.